Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Hair transplantation can successfully treat stubborn alopecia areata.

Model improves accuracy in predicting hair loss effects.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

Patchy alopecia areata can affect only pigmented hairs, leaving gray hairs untouched.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Herbs might help with hair loss, but more research is needed to confirm their safety and effectiveness.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Stress-related substance P may lead to hair loss and negatively affect hair growth.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

Minoxidil with triamcinolone acetonide is more effective for mild alopecia areata when injected with microneedles than when applied topically.

IL-4 gene variation may increase the risk of alopecia areata in Turkish people.

Plum-blossom needling with conventional treatments improves hair regrowth in alopecia areata.

Runx1 affects hair growth, cancer development, and autoimmune diseases in epithelial tissues.

The MTHFR C677T mutation may increase the risk of alopecia areata in the Turkish population.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.